While various growth factors are known to promote lymphangiogenesis [13], the interactions between ANGs and VEGF‐C in relation to clinical factors—such as tumor size [15], grade [16], and migration‐related characteristics like vascular or lymphatic invasion—have been less extensively studied [17]. Here, VEGFC is linked to neoplasm.